BY THE Ordering OF Pharmaceutical Import Profile — Turks And Caicos (DGFT 2022–2026)

Name: BY THE Ordering OF Pharmaceutical Import Records from India — 2 Products, $93.3K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

BY THE Ordering OF — Pharmaceutical Importer Profile (2026) | 2 Products, $93.3K Trade | TransData Nexus

BY THE Ordering OF

Pharmaceutical Importer · Turks And Caicos · Diabetes & Endocrine Focus · $93.3K Total Trade · DGFT Verified

BY THE Ordering OF is a pharmaceutical importer based in Turks And Caicos with a total trade value of $93.3K across 2 products in 2 therapeutic categories. Based on 34 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. BY THE Ordering OF sources from 1 verified Indian supplier, with Param Corporation accounting for 100.0% of imports.

BY THE Ordering OF — Import Portfolio & Supplier Network

BY THE Ordering OF import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to BY THE Ordering OF?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Param Corporation	$855.8K	2,366	100.0%

BY THE Ordering OF sources from 1 verified Indian supplier across 1,496 distinct formulations. The sourcing is highly concentrated — Param Corporation accounts for 100.0% of total imports, indicating a strategic single-source relationship.

What Formulations Does BY THE Ordering OF Import?

Formulation	Value	Ships
Medicines for consumption and the	$194.7K	584
Medicines for consumption and the description of the article / ods / product / item elistin forte 2 miu INJ	$30.8K	2
Medicines for consumption and the description of the products boostrix 0 5ML diphtheria tetanus 1 pfs batch no	$29.2K	4
Boostrix 0.5ML [diphtheria tetanus] batch no:ac37b481ac mfg dt:sep-23 exp	$20.0K	2
Medicines for consumption and the description of the products:jardiance 10MG (empagliflozin),Pack:9 x	$16.4K	3
Medicines for consumption and the description of the products:elistin forte 2miu INJ ( colistimethate	$13.0K	3
Medicines for consumption and the description of the products:sibofix-550 550MG (rifaximin),Pack:10 x	$10.1K	5
Medicines for consumption and the description of the products (itraconazole) it-mac 100 CAPS,Pack 10 x	$9.5K	2
Medicines for consumption and the description of the products eliquis 2 5MG apixaban Pack 30 TAB	$9.3K	3
Medicines for consumption and the description of the products :it-mac 100 CAPS itraconazole,Pack-10 x	$9.3K	1
Medicines for consumption and the description of the products: it-mac 100 CAPS itraconazolepack-10 x	$9.2K	2
Medicines for consumption and the description of the productsvarilrix INJ 0.5mlvaricella-zoster virus	$9.2K	2
Medicines for consumption and the description of the products:empagliflozin jardiance 25MG tabpack:9 x	$8.6K	2
Medicines for consumption and the description of the products hydrocort 100 mginj hydrocortisone sodium	$8.5K	1
Medicines for consumption and the description of the products:empagliflozin jardiance 10MG tabpack:9 x	$8.1K	1

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Empagliflozin	Diabetes & Endocrine	$84.9K	28	1.3%	14
2	Adalimumab	Biologics & Immunotherapy	$8.5K	6	0.7%	8

BY THE Ordering OF imports 2 pharmaceutical products across 2 categories into Turks And Caicos totaling $93.3K.

BY THE Ordering OF — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

BY THE Ordering OF is a pharmaceutical importer based in the Turks and Caicos Islands, specializing in the procurement of finished pharmaceutical formulations. The company operates as a buyer, sourcing medications from international suppliers to meet the healthcare needs of the local population. While specific details about its parent company and corporate structure are not publicly available, BY THE Ordering OF plays a pivotal role in the pharmaceutical distribution network of the Turks and Caicos Islands. By importing a diverse range of pharmaceutical products, the company ensures the availability of essential medications, thereby supporting the healthcare infrastructure of the region.

2Distribution Network

The distribution network of BY THE Ordering OF encompasses the importation of pharmaceutical products from international suppliers, notably from India. The company manages the logistics of these imports to ensure timely delivery and compliance with local regulations. While specific details about warehouse locations and logistics capabilities are not publicly disclosed, the company's operations are designed to effectively serve the healthcare needs of the Turks and Caicos Islands.

3Industry Role

In the pharmaceutical supply chain of the Turks and Caicos Islands, BY THE Ordering OF functions primarily as a pharmaceutical importer. The company sources finished pharmaceutical formulations from international suppliers, particularly from India, and facilitates their entry into the local market. By doing so, BY THE Ordering OF ensures the availability of a wide array of medications, contributing to the overall health and well-being of the island's residents.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — BY THE Ordering OF

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

BY THE Ordering OF's sourcing strategy exhibits a high degree of concentration, with a significant majority of its pharmaceutical imports originating from a single supplier, PARAM CORPORATION. This supplier has been responsible for 100% of the company's shipments, amounting to a total value of $856,000 across 2,366 shipments. This exclusive sourcing arrangement indicates a deep-rooted and stable relationship between BY THE Ordering OF and PARAM CORPORATION. While such concentration can lead to favorable terms and streamlined operations, it also presents potential risks. Any disruptions in PARAM CORPORATION's operations—such as production issues, logistical challenges, or regulatory changes—could directly impact BY THE Ordering OF's ability to meet the pharmaceutical demands of the Turks and Caicos Islands. Therefore, it is crucial for BY THE Ordering OF to maintain a robust contingency plan and consider diversifying its supplier base to mitigate potential risks associated with this high level of sourcing concentration.

2Supply Chain Resilience

The resilience of BY THE Ordering OF's supply chain is closely tied to its exclusive reliance on PARAM CORPORATION for pharmaceutical imports. This singular sourcing strategy may limit the company's ability to quickly adapt to supply chain disruptions, such as production delays or logistical challenges faced by PARAM CORPORATION. The lack of backup suppliers further exacerbates this vulnerability, potentially leading to shortages of essential medications in the Turks and Caicos Islands. To enhance supply chain resilience, BY THE Ordering OF should consider establishing relationships with additional suppliers and diversifying its product formulations. This approach would provide alternative sources for critical medications, ensuring a more stable and reliable supply chain capable of meeting the healthcare needs of the local population.

Importing Pharmaceuticals into Turks And Caicos — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Turks And Caicos

1Regulatory Authority & Framework

The regulation of pharmaceutical imports in the Turks and Caicos Islands is overseen by the Department of Agriculture's Animal Health Services Division. This division is responsible for ensuring that all imported pharmaceutical products meet the necessary health and safety standards before they are permitted entry into the islands. Key legislation governing pharmaceutical imports includes the Control of Drugs Ordinance 1976, which categorizes controlled substances and outlines the requirements for their importation. The Ministry of Health, Agriculture, Sports and Human Services is actively reviewing and updating this ordinance to strengthen the regulation of controlled drugs, aiming to implement quality assurance systems that promote the rational use of these medicines. The marketing authorization pathway for Indian generics involves obtaining the necessary import permits and ensuring compliance with the established health and safety standards set forth by the regulatory authorities.

2Import Licensing & GMP

Import licensing requirements for pharmaceutical products in the Turks and Caicos Islands are stringent. Importers must obtain the relevant permits from the Department of Agriculture's Animal Health Services Division before bringing pharmaceutical products into the islands. These permits ensure that imported products comply with local health and safety standards. The recognition of Good Manufacturing Practice (GMP) certificates is crucial for the importation process. Certificates from recognized authorities, such as the European Union (EU) GMP, World Health Organization (WHO) GMP, and Pharmaceutical Inspection Co-operation Scheme (PIC/S), are typically accepted. Additionally, importers must possess wholesale distribution authorization to legally distribute pharmaceutical products within the Turks and Caicos Islands.

BY THE Ordering OF — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

BY THE Ordering OF's product category focus is primarily on the Diabetes & Endocrine therapeutic area, accounting for 90.9% of its imports, with a smaller emphasis on Biologics & Immunotherapy at 9.1%. This strategic focus aligns with the prevalent health concerns in the Turks and Caicos Islands, where diabetes is a significant public health issue. The company's importation of Empagliflozin, a medication used to manage type 2 diabetes, underscores its commitment to addressing the needs of diabetic patients. The market demand for these products is driven by the high incidence of diabetes and endocrine disorders among the local population, necessitating a steady supply of effective treatments.

2Sourcing Profile

BY THE Ordering OF's sourcing strategy is centered on importing generic drugs, particularly those used in the management of diabetes and endocrine disorders. The company's preference for finished pharmaceutical formulations, as opposed to raw Active Pharmaceutical Ingredients (APIs) or bulk drugs, indicates a focus on ready-to-use products that can be directly distributed to healthcare providers and pharmacies. India's well-established pharmaceutical industry, known for its adherence to international GMP standards, makes it a preferred sourcing destination for BY THE Ordering OF. This approach ensures the availability of high-quality, cost-effective medications that meet the therapeutic needs of the Turks and Caicos Islands.

Seller's Guide — How to Become a Supplier to BY THE Ordering OF

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to enter the Turks and Caicos pharmaceutical market by partnering with BY THE Ordering OF. The company's current sourcing pattern, heavily reliant on a single supplier, presents an opportunity for diversification. Indian exporters can leverage this by offering a diverse range of high-quality pharmaceutical products that meet the therapeutic needs of the local population. By establishing reliable supply chains and ensuring compliance with the regulatory standards of the Turks and Caicos Islands, new suppliers can position themselves as valuable partners to BY THE Ordering OF, thereby enhancing the stability and resilience of the pharmaceutical supply chain in the region.

2Requirements & Qualifications

Indian exporters seeking to supply pharmaceutical products to BY THE Ordering OF and the Turks and Caicos market must adhere to specific certifications and quality standards. These include holding valid GMP certificates from recognized authorities such as the EU GMP, WHO GMP, or PIC/S. Additionally, products must comply with the labeling requirements of the Turks and Caicos Islands, which mandate information in English and adherence to local regulations. Exporters should also ensure that their products meet the batch testing and

Frequently Asked Questions — BY THE Ordering OF

What products does BY THE Ordering OF import from India?

BY THE Ordering OF imports 2 pharmaceutical products across 2 categories. Top imports: Empagliflozin ($84.9K), Adalimumab ($8.5K).

Who supplies pharmaceuticals to BY THE Ordering OF from India?

BY THE Ordering OF sources from 1 verified Indian suppliers. The primary supplier is Param Corporation (100.0% of imports, $855.8K).

What is BY THE Ordering OF's total pharmaceutical import value?

BY THE Ordering OF's total pharmaceutical import value from India is $93.3K, based on 34 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does BY THE Ordering OF focus on?

BY THE Ordering OF imports across 2 categories. The largest: Diabetes & Endocrine (90.9%), Biologics & Immunotherapy (9.1%).

Get Full BY THE Ordering OF Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.